Paragon Bioservices is a contract research and manufacturing organization (CRO/CMO) whose mission is to accelerate the development and manufacturing of biopharmaceuticals -- from target validation and process development to GMP manufacturing. As a provider of biologics suitable for phase I-II clinical trials, Paragon is GLP and GMP compliant.

Paragon has global service agreements with 8 of the Top 10 pharmaceutical companies -- as well as 2 of the Top 5 biotechnology companies. In 2009, Paragon won the Eli Lilly Global Supplier Award and a "Preferred Outsourcing Vendor" award from Pfizer.

Paragon's multidisciplinary team of scientists have extensive experience in applied research and process engineering and are actively involved in some of the most challenging and promising areas of drug discovery and development -- from cancer, cardiovascular and diabetes research to aging and neurodegenerative diseases.